Skip to content
★ Sign in to follow
AI

ACP IV, L.P.

Shareholder
Related company / holding
Talphera, Inc.Aerie Pharmaceuticals Inc
Total declarations
13
Companies
2
▲ Purchases (2 ops.)
€3.3M
▼ Sales (1 ops.)
€3.5M

Latest filing published 18 Jul 2014 for Aerie Pharmaceuticals INC.

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 18 Feb 2011 · 5743 days ago · €2.5M
    -21.0%
    Entry US$77.20 · Close at T+365 US$61.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

ACP IV, L.P.: trading record in brief

Filings by ACP IV, L.P. span 2 companies, the busiest being Aerie Pharmaceuticals Inc and Talphera, Inc. Over a trading history stretching from 16 February 2011 to 16 July 2014, the count stands at 13 filings.

Market trades split into 2 purchases (€3.3M) and 1 sale (€3.5M). Sales outweigh purchases by €196k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2014 to date brings no purchases and 1 sale.

The record was last updated on 18 July 2014 with a transaction in Aerie Pharmaceuticals Inc. The last purchase on record was published on 1 November 2013, which is 4,756 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to ACP IV, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total

13 of 13 declarations